Skip to content

GW PHARMACEUTICALS PLC

CIK 0001351288

← back to feed
Revenue (TTM)
$531.45M
+8.1% YoY Q1 Apr 2021
Net Income (TTM)
−$48.66M
−139.1% YoY Q1 Apr 2021
EPS Diluted (TTM)
−$0.12
−75.0% YoY Q1 Apr 2021
Gross Margin
92.7%
Q1 Apr 2021
Operating Margin
-9.4%
Q1 Apr 2021
Net Margin
-9.2%
Q1 Apr 2021
Free Cash Flow (TTM)
−$186.54M
Q1 Apr 2021
Cash
$458.1M
Q1 Apr 2021
Total Debt
—
Q1 Apr 2021
Shares Outstanding
378.54M sh
Q1 Apr 2021

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings